Company: ARTL
Filing Date: 2025-10-31
Form Type: 8-K
Source: 0001640334-25-001930
Chunk: 2

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-10-31
Form: 8-K
Item: Item 1.01
Chunk 2
---
110,842.52                      70,376  
  Tamara Favorito      Director                        $19,792.93                      12,566  
  Gregory Gorgas       Director and Officer            $27,710.36                      17,592  

The participation of these Investors in the Offering was disclosed to, and approved by, the board and separately by the disinterested members of the board.

The foregoing descriptions of the Subscription Agreement, the Notes and the Warrants are not complete and are qualified in their entirety by reference to the full text of the Subscription Agreement, the Notes and the Warrants, copies of which are filed as Exhibit 10.1, 10.2, and 10.3, respectively to this Current Report on Form 8-K and are incorporated by reference herein.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information provided in Item 1.01 with respect to the issuances of the of the Notes, the Warrants and the Registrable Shares, pursuant to the Subscription Agreement is incorporated herein by reference.

Item 3.02. Unregistered Sales of Equity Securities.

The information provided in Item 1.01 with respect to the issuances of the of the Notes, the Warrants and the Registrable Shares, pursuant to the Subscription Agreement is incorporated herein by reference. The issuance of all such securities by the Company will not be registered under the Securities Act and are issued in reliance on the exemption from registration provided by Section 3(a)(9) and/or Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder, or under any state securities laws, but the resale of such Registrable Shares will be registered under the Registration Statement.

Item 9.01 Financial Statements and Exhibits